Insider Transactions in Q1 2021 at Lucira Health, Inc. (LHDX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2021
|
Brezoczky Kelly Lewis Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+24.6%
|
-
|
|
Mar 10
2021
|
Hansgregory C. Hartmann Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+50.0%
|
-
|
|
Mar 10
2021
|
Debkishore Mitra Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,250
+2.13%
|
-
|
|
Mar 10
2021
|
Tamanna Prashar Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11,475
+50.0%
|
-
|
|
Feb 09
2021
|
Erik T. Engelson President and Chief Executive |
BUY
Conversion of derivative security
|
Direct |
23,282
+50.0%
|
-
|
|
Feb 09
2021
|
Dan George CFO and Treasurer |
BUY
Conversion of derivative security
|
Direct |
24,013
+36.4%
|
-
|
|
Feb 09
2021
|
David Lamond Director |
BUY
Conversion of derivative security
|
Indirect |
146,385
+44.39%
|
-
|
|
Feb 09
2021
|
Brezoczky Kelly Lewis Executive Vice President |
BUY
Conversion of derivative security
|
Direct |
23,231
+50.0%
|
-
|
|
Feb 09
2021
|
Lior Susan Director |
BUY
Conversion of derivative security
|
Indirect |
6,223,795
+30.13%
|
$80,909,335
$13.6 P/Share
|
|
Feb 09
2021
|
Eclipse Gp Iii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,183,986
+30.09%
|
$54,391,818
$13.6 P/Share
|
|
Feb 09
2021
|
Eclipse Gp Iii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,039,809
+30.15%
|
-
|
|
Feb 09
2021
|
Tuff Yen Director |
BUY
Conversion of derivative security
|
Indirect |
2,241,668
+30.09%
|
$29,141,684
$13.6 P/Share
|
|
Feb 05
2021
|
Epiq Capital Group, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,461,764
+50.0%
|
$58,849,988
$17.0 P/Share
|
|
Feb 05
2021
|
Epiq Capital Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
9,694,761
+50.0%
|
$164,810,937
$17.0 P/Share
|